News Center

位置：

Honors Announcement

Group News

Media Reports

Shijiazhuang Sihua Pharmaceutical Granted Three More Utility Model Patents

Category:

Honors Announcement

发布时间：2020-02-28

【概要描述】 Recently, the National Intellectual Property Administration announced gratifying news: three research achievements independently developed by Shijiazhuang Sihua Pharmaceutical—“A Double-Layer Aseptic Stand-Up Pouch Infusion Packaging,” “A Double-Layer Aseptic Soft-Bag Infusion Sterilization Temperature-Control Device,” and “A Double-Layer Aseptic Dual-Chamber Soft-Bag Infusion Packaging”—have been granted patents by the National Intellectual Property Administration, with each receiving a Utility Model Patent Authorization Notice.

Recently, good news came from the National Intellectual Property Administration: three research achievements independently developed by Shijiazhuang Sihua Pharmaceutical—“A Double-Layer Aseptic Upright Bag Infusion Packaging,” “A Double-Layer Aseptic Soft-Bag Infusion Sterilization Temperature-Control Device,” and “A Double-Layer Aseptic Dual-Chamber Soft-Bag Infusion Packaging”—have been granted patents by the National Intellectual Property Administration, and the company has received notices of utility model patent authorization.

According to the R&D team, the utility model patent “A Double-Layer Aseptic Dual-Chamber Flexible Bag Infusion Packaging” provides a double-layer aseptic dual-chamber flexible bag infusion package in which the inner bag consists of two independent chambers, with the medicinal solution separately filled into each chamber under aseptic conditions. Prior to clinical use, medical personnel need only tear open the虚焊位 (seam) between the two chambers, thereby completing the mixing of the medicinal solutions within seconds, thus preventing contamination and resolving the storage challenges associated with multi-component products that are not mutually soluble over long periods. The two additional utility model patents—“A Double-Layer Aseptic Upright Bag Infusion Packaging” and “A Double-Layer Aseptic Flexible Bag Infusion Sterilization Temperature-Control Device”—effectively address the issues of inaccurate temperature measurement and suboptimal sterilization performance inherent in conventional double-layer infusion packaging, thereby providing more reliable and safer products for healthcare professionals and patients alike. These innovations hold broad application prospects and significant economic benefits.

The quantity and quality of intellectual property holdings have become key indicators for assessing technological innovation capability and overall strength. Continuous innovation has propelled the rapid development of Shijiazhuang Sihua Pharmaceutical, with innovation capacity serving as one of the primary drivers of the company’s growth. In recent years, Shijiazhuang Sihua Pharmaceutical has steadily increased its investment in research and development, leveraging the expertise of academician workstations, postdoctoral research stations, and collaborative research institutes with leading universities to actively encourage employees to challenge conventional thinking, embrace innovation, and continually enhance the company’s R&D capabilities. As a result, a steady stream of scientific and technological achievements has emerged; to date, the company has been granted a total of 77 patents, including 45 invention patents and 27 utility model patents.

Keywords:

Shisi Pharmaceutical Obtains Another Invention Patent

Arbidol Included in the COVID-19 Diagnosis and Treatment Protocol (Sixth Edition); Shijiazhuang No.4 Pharmaceutical Accelerates Production to Ensure Supply

Shisi Pharmaceutical Obtains Another Invention Patent

Arbidol Included in the COVID-19 Diagnosis and Treatment Protocol (Sixth Edition); Shijiazhuang No.4 Pharmaceutical Accelerates Production to Ensure Supply